Free shipping on all orders over $ 500

Farletuzumab

Cat. No. M25269
Farletuzumab Structure
Synonym:

MORAb-003

Size Price Availability
1mg USD 420  USD420 Custom Synthesis
5mg USD 1320  USD1320 Custom Synthesis
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a therapeutic humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer.

Chemical Information
CAS Number 896723-44-7
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Toshio Shimizu, et al. Clin Cancer Res. First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drυg Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors

[2] Xin Cheng, et al. Mol Cancer Ther. MORAb-202, an Antibody-Drυg Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity

[3] Seiya Sato, et al. Onco Targets Ther. Profile of farletuzumab and its potential in the treatment of solid tumors

[4] Anish Thomas, et al. Lung Cancer. Farletuzumab in lung cancer

[5] Whitney A Spannuth, et al. Expert Opin Biol Ther. Farletuzumab in epithelial ovarian carcinoma

Related Antibiotic Products
Ningnanmycin

Ningnanmycin is a cytosine nucleoside peptide antibiotic, which is a highly effective, low-toxic, non-accumulative, broad-spectrum fungicide.

Sulfacytine

Sulfacytine is a short-acting sulfonamide antibiotic.

Cefcapene pivoxil hydrochloride

Cefcapene pivoxil hydrochloride, the pivalate ester precursor form of Cefcapene, is an orally active third-generation cephalosporin with a wide spectrum of anti-bacterial activity. Cefcapene pivoxil hydrochloride has the potential for the palmoplantar pustulosis (PPP) research.

Kendomycin

Kendomycin is a polyketide antibiotic with significant antibacterial activity and tumor cytotoxicity. At low concentrations (MIC: 5 μg/mL), Kendomycin inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) strain COL. In addition, Kendomycin is an endothelin receptor antagonist and calcitonin receptor agonist.

Ceftobiprole

Ceftobiprole is a broad-spectrum cephalosporin with rapid bactericidal activity against Gram-positive bacteria such as Staphylococcus aureus, including methicillin-resistant strains (MRSA), and Gram-negative bacteria, with a MIC90 value of 2 μg/mL against MRSA.

  Catalog
Abmole Inhibitor Catalog




Keywords: Farletuzumab, MORAb-003 supplier, Antibiotic, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.